TSE:BHC Bausch Health Companies (BHC) Stock Price, News & Analysis C$8.30 +0.17 (+2.09%) (As of 07/26/2024 ET) Add Compare Share Share Today's RangeC$7.87▼C$8.3550-Day RangeC$8.02▼C$10.4652-Week RangeC$5.45▼C$15.43Volume715,513 shsAverage Volume381,908 shsMarket CapitalizationC$3.04 billionP/E RatioN/ADividend Yield0.76%Price TargetC$9.00 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider Trades Get Bausch Health Companies alerts: Email Address Bausch Health Companies MarketRank™ Stock AnalysisAnalyst RatingHold2.00 Rating ScoreUpside/Downside8.4% UpsideC$9.00 Price TargetShort InterestN/ADividend StrengthWeakBased on Four FactorsSustainabilityN/ANews Sentiment0.42Based on 17 Articles This WeekInsider TradingN/AProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.0.44 out of 5 stars 1.0 Analyst's Opinion Consensus RatingBausch Health Companies has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 2 hold ratings, and no sell ratings.Amount of Analyst CoverageBausch Health Companies has only been the subject of 1 research reports in the past 90 days.Read more about Bausch Health Companies' stock forecast and price target. Previous Next N/A Short Interest Short InterestThere is no current short interest data available for BHC. Previous Next 0.0 Dividend Strength Dividend YieldBausch Health Companies has a dividend yield of 0.76%, which is in the bottom 25% of all stocks that pay dividends.Dividend GrowthBausch Health Companies does not have a long track record of dividend growth.Read more about Bausch Health Companies' dividend. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for BHC. Previous Next 3.0 News and Social Media Coverage News SentimentBausch Health Companies has a news sentiment score of 0.42. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.62 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 17 news articles for Bausch Health Companies this week, compared to 2 articles on an average week.Search Interest31 people have searched for BHC on MarketBeat in the last 30 days. This is an increase of 35% compared to the previous 30 days.MarketBeat Follows3 people have added Bausch Health Companies to their MarketBeat watchlist in the last 30 days. This is an increase of 200% compared to the previous 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Bausch Health Companies insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 0.93% of the stock of Bausch Health Companies is held by insiders.Percentage Held by Institutions80.04% of the stock of Bausch Health Companies is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Bausch Health Companies' insider trading history. Previous Next 1.3 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Bausch Health Companies is -4.91, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Bausch Health Companies is -4.91, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Growth RatioBausch Health Companies has a PEG Ratio of 0.21. PEG Ratios below 1 indicate that a company could be undervalued.Read more about Bausch Health Companies' valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad WealthPressNew trading system called MSFT, NVDA & MSFTLook 2023 kind of sucked from a trading standpoint… Despite the market finishing 24% higher…. Just seven stocks did all of the work… Unless you were holding or actively trading those 7 stocks, your trading year probably wasn’t as fruitful as you had hoped… According to my research, my new trading system would have spotted all seven of the “Magnificent stocks” MONTHS before they reached the highs they are trading at today.Just follow this link here! About Bausch Health Companies Stock (TSE:BHC)Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health. The company operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The Salix segment provides gastroenterology products in the United States. The International segment sells aesthetic medical devices, branded pharmaceuticals, generic pharmaceuticals, and OTC products internationally. The Solta Medical segment engages in the sale of aesthetic medical devices. The Diversified segment offers pharmaceutical products in the areas of neurology and certain other therapeutic classes; generic products; ortho dermatologic; and dentistry products in the United States. The Bausch + Lomb segment offers products in the areas of vision care, surgical, and ophthalmic pharmaceuticals products. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.Read More BHC Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart BHC Stock News HeadlinesJuly 25 at 9:02 AM | msn.comBausch Health denies report of considering bankruptcy filingJuly 24 at 7:05 PM | marketwatch.comBausch Health responds to rumors, says it is not considering bankruptcyJuly 26, 2024 | Crypto Swap Profits (Ad)625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.July 24 at 7:05 PM | marketwatch.comBausch Health Shares Rebound From 52-Week Low; Company Disputes Bankruptcy RumorsJuly 24 at 7:05 PM | benzinga.comWhy Bausch health Shares Are Falling TodayJuly 24 at 7:05 PM | markets.businessinsider.comBausch Health Companies: Hold Rating Amid Bankruptcy Rumors and Financial UncertaintiesJuly 24 at 7:05 PM | msn.comBausch Health plunges on report of potential prepack Chapter 11 bankruptcyJuly 24 at 9:30 AM | americanbankingnews.comBausch Health Companies Inc. to Post FY2024 Earnings of $4.92 Per Share, Zacks Research Forecasts (TSE:BHC)July 26, 2024 | MarketBeat (Ad)We just added a $300 account credit to your MarketBeat subscriptionMarketBeat All Access is our complete suite of portfolio monitoring software, research tools, stock screeners, proprietary reports, and more. Upgrade today and get $300 off your 2024-2025 subscription. Free for 30 days.July 24 at 4:39 AM | theglobeandmail.comClosing Bell: Bausch Health Companies Inc up on Tuesday (BHC)May 27, 2024 | baystreet.caStock Rebound Alert on TD Bank and MoreMay 23, 2024 | finance.yahoo.comBausch Health, Canada Inc. Announces Additional Public Drug Plan Listings for PrUCERIS(R) (Budesonide) Aerosol Foam To Treat Mild to Moderate Distal Ulcerative Colitis in AdultsMay 15, 2024 | finanznachrichten.deBausch Health Companies Inc.: Bausch Health Announces 2024 Annual Meeting of Shareholder ResultsMay 14, 2024 | finanznachrichten.deBausch Health Companies Inc.: Bausch Health Announces Updates Related to Norwich XIFAXAN MattersMay 14, 2024 | finance.yahoo.comBausch Health Down 6.6% In US After Hours As Updates Related to Norwich XIFAXAN MattersMay 6, 2024 | finance.yahoo.comBausch Health Companies (NYSE:BHC investor three-year losses grow to 72% as the stock sheds US$388m this past weekMay 2, 2024 | benzinga.comWhy Bausch Health Companies Shares Are Falling After Q1 ResultsMay 2, 2024 | msn.comBHC Stock Earnings: Bausch Health Companies Misses EPS, Misses Revenue for Q1 2024See More Headlines Receive BHC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Bausch Health Companies and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/02/2024Today7/26/2024Next Earnings (Confirmed)8/01/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeTSE SectorMedical Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A Current SymbolTSE:BHC CUSIPN/A CIKN/A Webwww.valeant.com Phone514-744-6792FaxN/AEmployees20,270Year FoundedN/APrice Target and Rating Average Stock Price TargetC$9.00 High Stock Price TargetC$9.00 Low Stock Price TargetC$9.00 Potential Upside/Downside+12.2%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage2 Analysts Profitability EPS (Most Recent Fiscal Year)C($1.69) Trailing P/E RatioN/A Forward P/E Ratio1.65 P/E Growth0.21Net IncomeC$-455,000,000.00 Net Margins-5.07% Pretax MarginN/A Return on Equity-686.52% Return on Assets4.04% Debt Debt-to-Equity Ratio7,583.76 Current Ratio1.23 Quick Ratio0.58 Sales & Book Value Annual SalesC$8.97 billion Price / Sales0.33 Cash FlowC$1.03 per share Price / Cash Flow7.76 Book ValueC($3.04) per share Price / Book-2.64Miscellaneous Outstanding Shares366,800,000Free FloatN/AMarket CapC$2.94 billion OptionableNot Optionable Beta0.90 Beginners Guide To Retirement StocksClick the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free Report Key ExecutivesMr. Thomas J. Appio (Age 62)CEO & Director Comp: $3.76MMr. John S. Barresi (Age 51)Senior VP, Controller, Chief Accounting Officer & Interim CFO Comp: $1.09MMs. Seana Carson (Age 51)Executive VP & General Counsel Comp: $1.19MMr. Mirza DautbegovicSenior VP & COOMr. Josh CoyleSenior Vice President of Sales & SalixMs. Kathleen FitzpatrickSenior VP & Chief HR OfficerDr. Tage Ramakrishna M.D. (Age 50)Chief Medical Officer and President of R&D Mr. Jeff HartnessExecutive VP of Market Access, Commercial Operations, Neurology, Generics & Government AffairsDr. Graham JacksonSenior VP & Chief Quality OfficerMr. Cees HeimanSenior Vice President of Europe & CanadaMore ExecutivesKey CompetitorsValeant Pharmaceuticals InternationalTSE:VRXAphriaTSE:APHATilray BrandsTSE:TLRYCronos GroupTSE:CRONHydropothecaryCVE:THCXView All Competitors BHC Stock Analysis - Frequently Asked Questions How have BHC shares performed this year? Bausch Health Companies' stock was trading at C$10.63 at the beginning of the year. Since then, BHC shares have decreased by 21.9% and is now trading at C$8.30. View the best growth stocks for 2024 here. How were Bausch Health Companies' earnings last quarter? Bausch Health Companies Inc. (TSE:BHC) released its earnings results on Thursday, May, 2nd. The company reported $0.80 EPS for the quarter, missing the consensus estimate of $1.02 by $0.22. The business had revenue of $2.90 billion for the quarter, compared to analyst estimates of $2.98 billion. Bausch Health Companies had a negative net margin of 5.07% and a negative trailing twelve-month return on equity of 686.52%. How do I buy shares of Bausch Health Companies? Shares of BHC stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. What other stocks do shareholders of Bausch Health Companies own? Based on aggregate information from My MarketBeat watchlists, some other companies that Bausch Health Companies investors own include Chesapeake Energy (CHKAQ), Enbridge (ENB), Aurora Cannabis (ACB), Manulife Financial (MFC), BlackBerry (BB), Bank of Nova Scotia (BNS) and Toronto-Dominion Bank (TD). This page (TSE:BHC) was last updated on 7/26/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredWe recommended Nvidia in 2016, now we’re recommending this…The AI boom is just getting started. And the real wealth has still to be made…Porter & Company | SponsoredNEW AI developed by trader who won 1,129% (in 2 days)Earlier this year one legendary trader captured a 1,129% win (in just 2 days) ... LIVE in front of thousands o...Monument Traders Alliance | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock (June 12) This $2 trillion D.C. shock i...Timothy Sykes | SponsoredGrab a pen and write down this ticker - here's whyA megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredWhy is NVDA stumbling?July is historically the best month of the year for U.S. stocks. So why are everyone’s favorite tech stocks...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bausch Health Companies Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bausch Health Companies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
